Bain Capital Life Sciences Investors, LLC
Follow13F filer, CIK 1703031, Boston, MA
Bain Capital Life Sciences Investors, LLC reported $1,489,841,174 across 23 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 81.87% of the portfolio.
Accepted , ingested 13F-HR 0001193125-26-462089
- Period
- 2026-09-30
- Reported value
- $1.49B
- Holdings
- 23
- Top 10 weight
- 81.87%
- New
- 4
- Sold out
- 2
Part of the filer group Bain Capital Life Sciences Investors, LLC
Bain Capital Credit, LPBain Capital Fund XII, LP
- Bain Capital Credit, LP
- Bain Capital Fund XII, LP
- Bain Capital Fund XI, L.P.
- Bain Capital Investors LLC
- Bain Capital Life Sciences Fund III, L.P.
- Bain Capital Life Sciences Fund II, L.P.
- Bain Capital Life Sciences Fund IV, L.P.
- Bain Capital Life Sciences III General Partner, LLC
- Bain Capital Life Sciences Investors II, LLC
- Bain Capital Life Sciences IV General Partner, LLC
- Bain Capital Life Sciences Opportunities III GP, LLC
- Bain Capital Life Sciences Opportunities III, LP
- Bain Capital Life Sciences Opportunities IV GP, LLC
- Bain Capital Life Sciences Opportunities IV, L.P.
- Bain Capital Partners XII, LLC
- Bain Capital Partners XI, L.P.
- Bain Capital Prairie Holdings (GP), LLC
- Bain Capital Prairie Holdings, LP
- Bain Capital Prairie, LLC
- Bain Capital Public Equity, LP
- Bain Capital Public Equity Management II, LLC
- Bain Capital Venture Coinvestment Fund II, L.P.
- Bain Capital Venture Coinvestment II Investors, LLC
- Bain Capital Venture Fund 2016, L.P.
- Bain Capital Venture Fund 2019, L.P.
- Bain Capital Venture Investors 2019, LLC
- BAIN CAPITAL VENTURE INVESTORS, LLC
- Bain Capital Venture Partners 2016, L.P.
- Bain Charger Holdings, L.P.
- BCPE Derby (DE) SPV (GP), LLC
- BCPE Derby (DE) SPV, LP
- BCPE Derby GP, LLC
- BCPE Derby Investor, LP
- BCPE Eagle GP, LLC
- BCPE Eagle Investor, LP
- BCPE Nucleon (DE) SPV (GP), LLC
- BCPE Nucleon (DE) SPV, LP
- BCPE Nucleon Investors (GP), LLC
- BCPE Nucleon Investors, LP
- BCPE Seminole GP III LLC
- BCPE Seminole GP II LLC
- BCPE Seminole GP LLC
- BCPE Seminole Holdings III, L.P.
- BCPE Seminole Holdings II Intermediate LP
- BCPE Seminole Holdings IV, L.P.
- BCPE Seminole Holdings LP
- BCPE Watson (DE) Aggregator GP, LLC
- BCPE Watson (DE) Aggregator, LP
- BCPE Watson (DE) BML GP, LLC
- BCPE Watson (DE) BML, LP
Stakes and trades reported after 2026-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- SGRY SURGERY PARTNERS INC: 13D/A 30,055,197 shares, 22.96% of the class, 13D/A filed 2026-10-26, 0001193125-26-431228Timeline
Accepted , ingested - ADCT ADC THERAPEUTICS SA: 13G 14,825,625 shares, 9.99% of the class, 13G filed 2026-10-29, 0001193125-26-438199Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ADRXnew | +6,728,970 | $134M |
| TARSnew | +1,096,141 | $86.2M |
| ALKSadded | +1,213,047 | $49.2M |
| FRNMnew | +2,365,459 | $37.3M |
| DYNnew | +1,900,000 | $30.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| HTFLreduced | -4,000,000 | -$199M |
| DNTHexited | -362,470 | -$35.3M |
| KYTXreduced | -1,573,000 | -$10.7M |
| PHVSreduced | -200,000 | -$6.21M |
| UPBexited | -600,949 | -$4.16M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-462089, largest first. % of portfolio is the value over $1,489,841,174, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| KLRAKAILERA THERAPEUTICS INC | 22,583,268 | $258M | 17.31% | 0 | Timeline | ||
| HTFLHEARTFLOW INC | 4,448,158 | $221M | 14.85% | -4,000,000 | Timeline | ||
| ADRXADARX PHARMACEUTICALS INC | 6,728,970 | $134M | 9.01% | new | Timeline | ||
| ALKSALKERMES PLC | 3,150,985 | $128M | 8.57% | +1,213,047 | Timeline | ||
| NAMSNEWAMSTERDAM PHARMA COMPANY | 3,806,559 | $92.6M | 6.21% | -7 | Timeline | ||
| SVRASAVARA INC | 17,600,621 | $90.8M | 6.1% | 0 | Timeline | ||
| TARSTARSUS PHARMACEUTICALS INC | 1,096,141 | $86.2M | 5.78% | new | Timeline | ||
| PHVSPHARVARIS N V | 2,475,509 | $76.9M | 5.16% | -200,000 | Timeline | ||
| SLDBSOLID BIOSCIENCES INC | 9,808,819 | $70.9M | 4.76% | 0 | Timeline | ||
| OLMAOLEMA PHARMACEUTICALS INC | 7,085,249 | $61.2M | 4.11% | 0 | Timeline | ||
| COAGHEMAB THERAPEUTICS HLDGS INC | 1,650,000 | $50.9M | 3.42% | 0 | Timeline | ||
| CABACABALETTA BIO INC | 21,209,188 | $40.7M | 2.73% | +3,967,743 | Timeline | ||
| FRNMFREENOME INC | 2,365,459 | $37.3M | 2.5% | new | Timeline | ||
| DYNDYNE THERAPEUTICS INC | 1,900,000 | $30.6M | 2.05% | new | Timeline | ||
| CCCCC4 THERAPEUTICS INC | 7,171,910 | $23.9M | 1.6% | 0 | Timeline | ||
| XFORX4 PHARMACEUTICALS INC | 7,967,454 | $23.1M | 1.55% | 0 | Timeline | ||
| ANNXANNEXON INC | 4,437,731 | $18.8M | 1.26% | 0 | Timeline | ||
| AVIRATEA PHARMACEUTICALS INC | 2,075,639 | $10.8M | 0.73% | 0 | Timeline | ||
| IRONDISC MEDICINE INC | 141,234 | $9.25M | 0.62% | 0 | Timeline | ||
| KYTXKYVERNA THERAPEUTICS INC | 1,312,000 | $8.92M | 0.6% | -1,573,000 | Timeline | ||
| RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $8.69M | 0.58% | 0 | Timeline | ||
| XLOXILIO THERAPEUTICS INC | 664,021 | $6.01M | 0.4% | 0 | Timeline | ||
| NAMSWNEWAMSTERDAM PHARMA COMPANY | 99,999 | $1.26M | 0.08% | 0 | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-462089 | base | 2026-11-16 |